The Scientific World Journal

The Scientific World Journal / 2008 / Article
Special Issue

Focal Therapy for Prostate Cancer

View this Special Issue

Review Article | Open Access

Volume 8 |Article ID 621079 | https://doi.org/10.1100/tsw.2008.56

Duke K. Bahn, Paul D. Silverman, "Focal Cryoablation of Prostate: A Review", The Scientific World Journal, vol. 8, Article ID 621079, 6 pages, 2008. https://doi.org/10.1100/tsw.2008.56

Focal Cryoablation of Prostate: A Review

Academic Editor: Peter Nieh
Received25 Dec 2007
Revised18 Mar 2008
Accepted31 Mar 2008

Abstract

Current treatment options for men with early localized prostate cancer are either some form of radical therapy or active surveillance. Radical therapy is usually associated with significant adverse effects that might jeopardize a man's quality of life. Some observers believe that PSA screening has resulted in the over diagnosis and over treatment of prostate cancer. Many men are being diagnosed with an early stage, small volume, unifocal or unilateral prostate cancer but are reluctant to accept watchful waiting or active surveillance. Focal cryoablation is the less than complete ablation of the gland with ice. Based on review of the limited amount of material available in the current literature, focal cryoablation can provide acceptable cancer control while preserving sexual potency and urinary continence. Focal cryoablation may fill a void in the therapeutic options available to patients with unifocal or unilateral prostate cancer who have a strong desire to maintain their quality of life.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views229
Downloads445
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.